CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Products	$ 15,624	$ 5,600
Costs and Expenses
Costs of revenue	24,115	9,388
Research, development and manufacturing operations	558,744	607,233
Selling, general and administrative	950,771	1,060,041
Share-based compensation	211,513	259,234
Depreciation and amortization	16,911	20,757
Impairment loss		524,481
Total Costs and Expenses	1,762,054	2,481,134
Loss from Operations	(1,746,430)	(2,475,534)
Other Income/(Expense)
Other income/(expense), net	87,385	64,323
Interest expense	(15,251)	(126,555)
Total Other Income/(Expense)	72,134	(62,232)
Income/(Loss) on Equity Method Investments		24
Net Income/(Loss)	$ (1,674,296)	$ (2,537,742)
Net Income/(Loss) Per Share (Basic)	$ (1.13)	$ (53)
Net Income/(Loss) Per Share (Diluted)	$ (1.13)	$ (53)
Weighted Average Common Shares Outstanding (Basic)	1,487,291	47,581
Weighted Average Common Shares Outstanding (Diluted)	1,487,291	47,581
Other Comprehensive Income/(Loss)
Foreign currency translation gain/(loss)	$ 2,498	$ (1,712)
Net Comprehensive Income/(Loss)	(1,671,798)	(2,539,454)
Products
Products	$ 15,624	$ 5,600